Medication errors in the ambulatory treatment of pediatric attention deficit hyperactivity disorder.
Of 361 reports of errors involving pediatric attention deficit hyperactivity disorder from 2003 to 2005, 82% reached the patient but were not harmful; more serious errors were rare.
Bundy
David G
DG
Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, USA. dbundy@jhmi.edu
Rinke
Michael L
ML
Shore
Andrew D
AD
Hicks
Rodney W
RW
Morlock
Laura L
LL
Miller
Marlene R
MR
D000293:Adolescent; D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D000553:Ambulatory Care / Q000592:standards* / Q000706:statistics & numerical data; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D016208:Databases, Factual; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use; D006801:Humans; D008508:Medication Errors / Q000706:statistics & numerical data*; D014481:United States / Q000453:epidemiology
D018759:Adrenergic Uptake Inhibitors; D000697:Central Nervous System Stimulants; D018765:Dopamine Uptake Inhibitors